Purpose. Escherichia coli is a leading cause of bloodstream infection (BSI) in hospitals and communities.
INTRODUCTION
Bloodstream infection (BSI) is one of the leading causes of high mortality among infectious diseases worldwide. Escherichia coli is a common cause of BSI in both the community and hospital [1] . In England, E. coli accounted for 27 % BSIs and 54 % Gram-negative BSIs in 2016. It is predicted that by 2020/21, the incidence of E. coli BSI will be about 90.5 per 100 000 people and the 30-day case fatality rate will be 11.5 per 100 000 people [2] . This increase is mainly being driven by the emergence of new antibioticresistant strains. A study conducted in Malawi showed that extended spectrum b-lactamase (ESBL) production in E. coli BSI ranged from 0.7 to 30.3 % while resistance to ciprofloxacin rose from 2.5 to 31.1 % between 2003 and 2016 [3] . Consequently, there is an urgent need to estimate the clinical and molecular epidemiology of E. coli BSI in the hospital and community to develop effective preventive and management strategies against this infection.
Strain typing plays an important role in epidemiological surveillance. Serotypes of E. coli based on O and H antigens provide a classic typing method. More than 180 O antigens and 50 H antigens have been described [4] . Multilocus sequence typing (MLST) is another fast and accurate way to characterize the genetic diversity of micro-organisms [5] . The globally emerging O25b:ST131 E. coli clone poses a great threat to public health [6] .
However, there is still need for more detailed serotyping and MLST data to assess the epidemiology of E. coli BSI.
It is noteworthy that E. coli possesses broad virulence factors (VFs), which helps it to overcome host defences, damage cells and induce inflammatory responses. VFs can be categorized into several functional groups such as adhesins, toxins, protectins and iron acquisition systems [7] . Further investigation of VFs can help to explore the pathogenicity of bacteria. Currently, there are few studies on E. coli virulence distribution in the community and hospital [8] . Here, we describe the clinical features and microbiological characteristics of E. coli BSIs alongside their relationships in hospitals and communities.
METHODS

Study setting
A retrospective analysis was conducted at the First Affiliated Hospital, Zhejiang University School of Medicine, a tertiary teaching hospital in Zhejiang, southern China. Patients with E. coli BSI presenting in 2015 were eligible. Only patients with two consecutive positive blood cultures of E. coli were included and strains isolated from the first episode were analysed. Hospital-onset (HO) infection was defined as the first positive blood culture obtained 48 h after hospitalization including patients who were transferred from other hospitals. Otherwise the infection was considered as community-onset (CO) [9] . The study was approved by the Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University.
Data collection
Patient data were collected from the medical records including demographics, chronic comorbidities, surgery within 2 weeks, invasive procedures and devices (previous week) and Pitt score, and then used to assess BSI severity [10] . The use of glucocorticoid, chemotherapy or other immunosuppressive therapy in the previous 30 days was considered as indicating immunosuppression. The source of infection was determined based on clinical presentation and the isolation evidence of presumed portals of entry. If the infection source was unclear and without a concurrent positive culture from another site, it was termed 'primary bacteraemia' [11] . Clinical outcome was estimated by 30-day mortality and length of hospital stay after infection (only in-patients were included).
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed by using the automated Vitek 2 system (bioM erieux) and the results were interpreted based on Clinical and Laboratory Standards Institute (CLSI) guidelines [12] . Antimicrobial panels included ampicillin, ampicillinsulbactam, piperacillin-tazobactam, imipenem, ertapenem, cefotetan, cefazolin, ceftazidime, ceftriaxone, cefepime, sulfamethoxazole-trimethoprim, aztreonam, gentamicin, amikacin, ciprofloxacin and levofloxacin. Multidrug-resistant (MDR) was defined as acquired non-susceptibility to one or more agent in three or more antimicrobial categories. Extensively drug-resistant (XDR) was defined as acquired non-susceptibility to one or more agent in all except two or fewer categories. Pandrug-resistant (PDR) was defined as acquired non-susceptibility to all antimicrobial agents [13] . E. coli ATCC 25922 was used as the quality control strain.
Serotyping
The serotype of isolates was determined via E. coli-specific 43 O and 22 H antisera (Denka Seiken Company). O antigen serotyping was performed through the slide agglutination method. H antigen serotyping was identified with the test tube agglutination method according to the product guide. Isolates with no reaction to any O or H antisera were defined as OUT (O antisera untypeable) or HUT (H antisera untypeable), respectively.
Virulence factor gene analysis The presence of 42 VF genes of E. coli was detected by PCR as described [14] . All positive VFs of each isolate were summed to give a VF score [15] . The VF genes were as follows: papACEFG (P fimbriae), iha (adhesion siderophore), afa/draBC (Dr binding adhesin), sfa/foc (S/F1C fimbriae), sfaS (S fimbriae), focG (F1C fimbriae), f17 (F17c fimbriae), hra (heat-resistant haemagglutinin), gafD (G fimbriae), afaE8 (afimbrial adhesin VIII), bmaE (M fimbriae), clpG (CS31A adhesin), hlyDF (a-haemolysin), cdtB (cytolethal distending toxin), sat (secreted autotransporter toxin), vat (vacuolating toxin), pic (serine protease), cnf1 (cytotoxic necrotizing factor), tsh (temperature sensitive haemagglutinin), astA (enteroaggregative E. coli toxin), Kps III (group III capsule), K1/K5/K15 (K1/K5/K15 group 2 capsule variants), traT (serum resistance), cvaC (olicin V), rfc (O4 LPS synthesis), fyuA (yersiniabactin receptor), iss (increased serum survival), iroN (salmochelin receptor), iutA (aerobactin receptor), ireA (siderophore receptor), clbB (colibactin hybrid peptide-polyketide synthesis), usp (uropathogenic specific protein), clbN (colibactin non-ribosomal synthesis), ompT (outer membrane protease T), H7fliC (flagellin variant) and ibeA (invasion of brain endothelium).
Multilocus sequence typing
Seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA) of E. coli were used for MLST as previously described [16] . Sequences were compared online (http:// mlst.warwick.ac.uk/mlst/dbs/Ecoli) to obtain specific allele numbers and corresponding sequence types (STs). Nucleotide sequence analyses were performed using MEGA (version 5.05) with the neighbour-joining (NJ) method.
Statistical analysis
Data are presented as mean±SD, median (interquartile range), and number or percentage. Categorical variables were assessed with the chi-square test or the Fisher exact test while continuous variables were evaluated by the Mann-Whitney U test. A two-tailed P value <0.05 was regarded as statistically significant. All tests were performed by SPSS (version 22.0).
RESULTS
Clinical characteristics
A total of 100 patients with E. coli BSI were enrolled in this study, among whom 60 (60 %) had HO infection and 40 (40 %) had CO infection. The patients were predominantly elderly with community origin episodes (66.6±13.80 vs. 55.3 ±16.78 years, P<0.001) ( Table 1 ). The major comorbidities were hypertension (35 %), diabetes mellitus (20 %), malignancy (19 %), haematological disorder (16 %) and liver cirrhosis (15 %). Compared to HO BSI, patients with CO BSI had higher percentages of hypertension (50 vs. 25 %, respectively; P=0.010) and chronic kidney disease (17.5 vs. 6.5 %, respectively; P=0.090). Stratifying by age, the proportion of elderly (>65 years) was 75 % among patients with hypertension in CO BSI and 66.7 % for HO BSI (Table S1 , available in the online version of this article). The proportion of elderly patients was 28.6 % among those with chronic kidney disease in CO BSI and 0 % for HO BSI (Table S2 ). HO BSI was more likely to occur in immunosuppressed patients (36.7 vs. 7.5 %, respectively; P=0.001) and those who underwent surgery within 2 weeks (28.3 vs. 10 %, respectively; P=0.027). The most frequent invasive procedures and devices used were central venous catheter (14 %), followed by surgical drainage (10 %). The source of infection was primary bacteraemia, biliary tract and urinary tract at 46, 24 and 16 %, respectively. No difference was found in Pitt score for either HO or CO BSI. The 30-day mortality was higher in CO BSI than HO BSI (28.3 vs. 7.5 %, respectively; P = 0.011) while a comparison of the length of hospital stay after infection showed no significant difference between the groups.
Antimicrobial profiles of E. coli BSI The antimicrobial resistant percentages of E. coli isolated from 100 BSI pateints are shown in Table 2 . Among these isolates, 81 were MDR and 60 were ESBL-positive. Most of the isolates showed high frequencies of resistance to ampicillin (85 %), ampicillin-sulbactam (65 %), ciprofloxacin (59 %) and levofloxacin (57 %). Resistance percentages to amikacin, ertapenem and imipenem were <5 %. Regarding cephalosporins, the prevalences of resistance to cefazolin, ceftriaxone, ceftazidime and cefepime were 66, 63, 27 and 20 %, respectively. There was no statistical difference in antimicrobial profiles and MDR patterns between HO and CO infections (Tables 2, 3 and S3).
Prevalence of serotype
Among the 100 isolates, the total serum agglutination rate was 52 %. Thirteen O and nine H serogroups were detected. The top three O and H serogroups were O1 (6 %), O25 (4 %) and O15 (3 %) and H51 (9 %), H4 (9 %) and H5 (7 %), respectively. Serotype distributions of E. coli in HO and CO BSI are shown in Table 4 .
Distribution of virulence factor genes
The most common VF gene was iutA carried by 66 % of isolates, followed by traT (61 %), usp (39 %), iha (34 %) and ompT (30 %) ( Table 5 ). All isolates were negative for gafD, afaE8, clpG, pic, K5 and ibeA. For adhesins, papA, papC and papEF were more frequently observed in isolates from CO BSI than HO BSI (P=0.008, 0.004 and 0.022, respectively) while others showed no difference between the two groups. The median VF score was higher in CO BSI as compared to HO BSI although no significant difference was found (5.5 vs. 5, respectively; P=0.058).
MLST analysis and phylogenetic relationships
The sequences in this study were analysed via the Sanger method. Since the University of Warwick only accepts data sequenced by Illumina, the new sequences of alleles and 15 new STs could not be submitted to the Warwick database for further analysis. MLST analysis categorized the 85 isolates into 43 different STs. The main clonal complex (CC) detected was CC131 included in 15 isolates, comprising ST131 (n=13), ST2657 (n=1) and ST3730 (n=1). The second CC detected was CC10 in 12 isolates, containing ST10 (n=4), ST167 (n=4), ST43 (n=1), ST744 (n=1), ST4383 (n=1) and ST6852 (n=1) (Fig. 1) . On the other hand, the most common ST was ST131 (15.3 %), followed by ST1193 (7.1 %), ST95 (5.9 %) and ST69 (5.9 %). Phylogenetic relationships of STs with respect to VF genes, VF score, ESBLs, patient outcome and BSI acquisition are shown in Fig. 1 . Forty (47.1 %) isolates possessed more than five VF genes. In the frequently detected STs, high VF scores (mean >7) were obtained in ST131, ST1193 and ST95. Among the five patients carrying strains of CC155, three died.
DISCUSSION
E. coli is one of the major sources of BSIs and is associated with high mortality, thus posing a huge threat to public health [1] . This study compares HO and CO E. coli BSI in terms of clinical features and microbiological characteristics. To our knowledge, this is the first study to analyse microbiological characteristics in terms of antimicrobial susceptibility, serotype, MLST and VFs to explore the epidemiology of E. coli BSI in the hospital and community.
The majority (60 %) of E. coli BSI isolates in our study originated in the hospital while most cases in New Zealand and England were CO [17, 18] . The clinical manifestations of E. coli BSI are different between the hospital and community. In this study, patients were older in the CO group, which matches the marked increase in incidence of CO E. coli BSI in the elderly observed in France. This may be due to previous antibiotic exposure in older people [19] . Among comorbidities, hypertension and chronic kidney disease were more common in the CO group in this study. The proportion of elderly was high in BSI patients with hypertension. Because patients in the CO group were older than those in the HO group, the difference in hypertension between the two groups may be attributed to the age difference. In addition, the low proportion of elderly patients with chronic kidney disease probably indicates that the difference between the two groups is caused by the comorbidity itself, although no significant difference was found due to the small sample size (P=0.491) (Table S2 ). However, attention needs to be given to patients with chronic kidney disease in the community as they may be more susceptible to bacteraemia, with improper home dialysis therapy and urinary tract infection (UTI) being two possible factors contributing to increased susceptibility [20] .
Immunosuppression and surgery are two well-recognized risk factors of HO BSI. Pathogens are more able to infect immunocompromised hosts and surgery is often associated with surgical drainage and central venous catheter-related infections, which are two common causes of HO BSI [21] . Consistent with previous studies, we found that the urinary tract was a more common source of CO BSI compared to HO BSI, although no statistical difference was found between the two groups [22, 23] . Treatment failure in UTI is a risk factor of developing E. coli bacteraemia. This indicates that close attention should be given to urine culture and drug susceptibility testing for patients with UTI to improve diagnosis and management [23] . The 30-day mortality in HO infections observed here was relatively higher than those reported elsewhere [17] . As ours is a tertiary referral hospital, more severe patients may have been hospitalized, leading to a higher mortality rate in our study.
The emergence and spread of ESBL-producing E. coli pose a great threat to public health. This study indicated that 60 % of the E. coli isolates were ESBL-producing, which is comparable to rates reported from Shanghai (67.8 %), but much higher than in Korea (21.5 %), France (13.5 %), Japan (16.4 %) and New Zealand (5.6 %) [17, [24] [25] [26] [27] . CTX-M enzymes are the most prevalent ESBLs, with strong hydrolytic activity against cefotaxime and ceftriaxone but not ceftazidime. Among theses enzymes, CTX-M-15 and CTX-M-14 are most commonly detected in patients. Notably, CTX-M-15, the variant with enhanced ceftazidimase activity, has now disseminated globally [28] . However, many studies have reported that CTX-M-14 is still the predominant genotype in China [21, 29, 30] . This may explain the distinct difference in resistance percentages observed between the two third-generation cephalosporins [ceftriaxone (63 %) vs. ceftazidime (27 %) ] in this study. Fluoroquinolone resistance was also found to be much higher in this study and in Shanghai as compared to western countries [25, 31, 32] . It has also been reported that plasmid-mediated quinolone resistance (PMQR) genes often coexist with ESBL genes on the same plasmid in Enterobacteriaceae [33] . The high proportion of ESBL-producing and fluoroquinolone-resistant strains is expected to be a great therapeutic challenge to the medical profession.
Earlier studies reported that ESBL-producing and fluoroquinolone-resistant strains were more frequent in HO infections than CO infections. However, no differences in antimicrobial resistance agents and multi-drug resistance patterns of E. coli were found between HO and CO BSI in this study [17, 18] . In China, it is easy to obtain first-line antibiotics such as fluoroquinolones and cephalosporins in community settings, which results in antibiotic misuse due to self-medication. Moreover, the excessive use of antibiotics has also been observed in animal husbandry and aquaculture practices [34] . In addition, faecal carriage rates of ESBL-producing E. coli are high among healthy individuals in the Chinese community, ranging from 41.8 to 82.6 % [21] . All these factors could be of great selective pressure in E. coli and may further lead to an expansion of MDR strains throughout the community. Therefore, bacterial monitoring in humans and animals should be enhanced and rationalizing the use of antibiotics should be considered a national priority.
VFs are responsible for bacteria pathogenesis and vary in each strain. The high proportion of iutA (66 %) and traT (61 %) in E. coli BSI in the current work is in agreement with data from Korea and Denmark, but the distribution of other VF genes was different compared to findings in these countries [14, 35] . This suggests that virulence profiles may depend on geographical region [36] . The composition of VF genes in this study closely matches those isolated from urinary tract and biliary tract diseases [14, 37] . This may be explained by the fact that nearly half of all BSIs originate in the biliary tract and urinary tract. In this work, adhesin genes papA, papC and papEF were more associated with CO BSI rather than HO BSI. The pap genes code for P fimbriae, an important adhesin factor in uropathogenic E. coli (UPEC) that can induce an inflammatory reaction and is associated with acute UTI [38] . The higher prevalence of pap genes in the CO group may indicate a higher UTI rate in this region of study than previoulsy documented. The results in this study suggest that some BSIs originating in the urinary tract may be considered as primary bacteraemia due to the incomplete medical records of outpatients. E. coli isolated from HO BSI carried a lower median VF score, possibly due to malignancy, haematological disorders or other immunosuppression conditions in hospitalized patients, increasing the likelihood of BSI from less virulent E. coli [39] .
Since its initial identification in 2008, E. coli ST131 has emerged as a pandemic clone worldwide and is responsible for one-third of CO E. coli BSI [40] . Similarly, ST131 (n=13) was found to be most common ST in this study and half of ST131 (53.8 %) isolates caused CO BSI. Although O25b:H4 is the most prevalent serotype in ST131 clades [6] , only one isolate belonging to ST155 was identified as O25:H4 in this study. Among the frequently detected STs, ST131, ST1193 and ST95 had high VF scores, suggesting that strains carrying more VFs may be better adapted to different environments and hosts. This study found no correlations between mortality and high VF scores, specific VFs or phylogenetic background, as reported previously [40] . This indicates that other factors may contribute more to the patient's outcome, such as antibiotic resistance and host characteristics. Of note, three of the five patients carrying CC155 died. Medical records showed that these patients were admitted to the hospital at different times and to different wards. Further studies using a larger number of samples should investigate the relationship between mortality and CC155. Fig. 1 shows that strains carrying similar VFs were often clonally related. The majority of the clones in the present study were able to cause both CO and HO BSI. However, active surveillance is needed to monitor specific clone dissemination and outbreaks in the community and hospital settings.
Among the limitations of the current study are that it is a retrospective single-centre trial with a relatively small sample size that might result in some bias. Secondly, due to insufficient clinical records, CO infections could not be further divided into community-associated and healthcareassociated infections. Recently, healthcare-associated infections have been reported to have epidemiological features overlapping with both CO and HO infection. For instance, previous studies found a higher antimicrobial resistance to organisms in healthcare-associated BSI than community-associated BSI [17] , which partially explains the lack of a difference in antibiotic resistance between CO and HO BSI in this study.
Conclusion
We found that HO and CO E. coli BSI have different clinical characteristics but similar antibiotic resistance profiles. Serotypes and STs of the isolates showed great diversity in the study region, but their similar distribution in hospital and community patients implied no single specific clone outbreak. The distribution of VF genes varied between clones. The papA, papC and papEF genes were more frequently observed in CO BSI compared to HO BSI.
